FindTrial
Sign In

TO STUDY OF EFFICACY OF SUBCUTANEOUS INJECTION OF APAMARGA KSHARODAKA WITH AGNIKARMA IN MANAGEMENT OF WARTS

COMPARATIVE STUDY OF EFFICACY OF SUBCUTANEOUS INJECTION OF APAMARGA KSHARODAKA WITH AGNIKARMA IN MANAGEMENT OF WARTS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040903
Enrollment
60
Registered
2022-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Tilak Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having Mashak (Warts) irrespective of sex, age, occupation including surgical wounds 2) OPD & IPD patients form Shalya Department of affiliated hospital 3) Mashak having dimention 0.1mm to 10mm 4) Patients ready to give written consent will be selected 5) Patients suffering from mashaklakshana -Avedana (not painful) -Sthir(stable) -Gatreshudrushate(on skin surface) -Mashvat(black gram whole) -Krushanutsann(patches of overgrowth skin)

Exclusion criteria

Exclusion criteria: 1.Keloid 2.Sebacious cyst 3.Dermoid cyst 4.Fibrosarcoma 5.Tubercurosis-Patient suffering and receiving treatment 6.Patient suffering from HIV 7.molluscumcontagiosum 8.Focal epithelial hyperplasia 9.Anogenital warts 10 Bowenoidpapulosis 11.Seborrheic keratosis 12.Corns 13.Callus 14.Recently underwent saliclic there

Design outcomes

Primary

MeasureTime frame
COMPARATIVE STUDY OF EFFICACY OF SUBCUTANEOUS INJECTION OF APAMARGA KSHARODAKA WITH AGNIKARMA IN MANAGEMENT OF WARTSTimepoint: WARTS FALL WITHIN 1 TO 2 WEEKS—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactVd Avinash Balajirao Lakshatwar

Tilak Ayurveda Mahavidyalaya

rashmibhise@gmail.com9960163181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026